AI assistant
DEXCOM INC — Director's Dealing 2021
Jan 26, 2021
30198_dirs_2021-01-25_b9aa3b08-0b5e-4fd3-9c68-1298b191f273.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2021-01-22
Reporting Person: DOUBLEDAY RICHARD (EVP Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-22 | Common Stock | S | 366 | $367.5132 | Disposed | 9617 | Indirect |
| 2021-01-22 | Common Stock | S | 169 | $368.2021 | Disposed | 9448 | Indirect |
| 2021-01-22 | Common Stock | S | 254 | $369.3065 | Disposed | 9194 | Indirect |
| 2021-01-22 | Common Stock | S | 310 | $370.2438 | Disposed | 8884 | Indirect |
| 2021-01-22 | Common Stock | S | 11 | $371.9841 | Disposed | 8873 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 21524 | Direct |
Footnotes
F1: On June 15, 2020, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2: This transaction was executed in multiple trades at prices ranging from $366.87 to $367.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.
F4: This transaction was executed in multiple trades at prices ranging from $367.90 to $368.49. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F5: This transaction was executed in multiple trades at prices ranging from $369.16 to $369.82. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F6: This transaction was executed in multiple trades at prices ranging from $370.240 to $370.595. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F7: This transaction was executed in multiple trades at prices ranging from $371.675 to $372.015. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.